OVID

$2.79+0.02 (+0.72%)

Market ClosedLast close May 1

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

No data available for this range. Intraday data may be limited by the exchange.

Loading stock data…